Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability

4 Apr 2016

Abstract excerpt

// Maria Carmela Cantisani 1 , Alessia Parascandolo 2 , Merja Perälä 3, 4 , Chiara Allocca 2 , Vidal Fey 3, 4 , Niko Sahlberg 3, 4 , Francesco Merolla 5 , Fulvio Basolo 6 , Mikko O. Laukkanen 1 , Olli Pekka Kallioniemi 7 , Massimo Santoro 2, 8 , Maria Domenica Castellone 8 1 IRCCS SDN, Naples, Italy 2 Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita’ Federico II, Naples, Italy 3 Medical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Hippo pathway signaling and YAP/TAZ
Share to Thyroid Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27058903
DOI: 10.18632/oncotarget.8577

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viabilityPMID 27058903Read ↗

Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningSemantic proximity Read ↗

Identification and characterization of potential novel targets in thyroid carcinoma : evidence of non-oncogene addiction unveiling tumor cell vulnerabilitiesSemantic proximity Read ↗

Genetic mutations in thyroid carcinoma.Semantic proximity Read ↗

Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathwaySemantic proximity Read ↗

How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy.Semantic proximity Read ↗

Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations.Semantic proximity Read ↗

Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodules.Semantic proximity Read ↗

Cellular apoptosis susceptibility (CAS) is overexpressed in thyroid carcinoma and maintains tumor cell growth: A potential link to the BRAFV600E mutation.Semantic proximity Read ↗

Analysis of the Role of FRMD5 in the Biology of Papillary Thyroid Carcinoma.Semantic proximity Read ↗

RET kinase inhibitors: a review of recent patents (2012–2015)Semantic proximity Read ↗

PRKAR1A and Thyroid TumorsSemantic proximity Read ↗

ß-catenin signaling is required for RAS-driven thyroid cancer through PI3K activationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.